Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome

Walter Michaeli, Ina Michaelis, Joachim Grosse, Matthias Von Walter, Habil Erich Wintermantel, Nina Laar

Publikation: Beitrag in Buch/Bericht/KonferenzbandKonferenzbeitragBegutachtung

1 Zitat (Scopus)

Abstract

The overactive bladder syndrome (OAB) is defined as a symptom complex which is characterized with frequent urination, urinary incontinence and a strong, sudden urge to urinate even when the bladder is not full. About 10% of the total population have OAB and it occurs in every age group. Apart from the medical, oral therapy, the so called intravesical instillation is used as well. In order to minimise the numerous side effects of the oral therapy like dry mouth, dizziness or depressions a biodegradable, active agent carrying implant for the intravesical therapy of the OAB was aspired. After a project period of two years a biodegradable, active agent carrying polymer implant could be developed.

OriginalspracheEnglisch
Titel67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009
Seiten2951-2956
Seitenumfang6
PublikationsstatusVeröffentlicht - 2009
Extern publiziertJa
Veranstaltung67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009 - Chicago, IL, USA/Vereinigte Staaten
Dauer: 22 Juni 200924 Juni 2009

Publikationsreihe

NameAnnual Technical Conference - ANTEC, Conference Proceedings
Band5

Konferenz

Konferenz67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009
Land/GebietUSA/Vereinigte Staaten
OrtChicago, IL
Zeitraum22/06/0924/06/09

Fingerprint

Untersuchen Sie die Forschungsthemen von „Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren